dostęp płatny
Perspektywy terapii oksytocyną u osób z zespołem łamliwego chromosomu X manifestującym się zaburzeniami ze spektrum autyzmu — neurobiologiczne wyjaśnienie zasadności stosowania i przegląd aktualnych danych
- Zakład Farmakologii, Wydział Nauk Medycznych w Katowicach, Śląski Uniwersytet Medyczny, Katowice
- Zakład Pedagogiki Katedry Nauk Społecznych i Humanistycznych, Wydział Nauk o Zdrowiu w Katowicach, Śląski Uniwersytet Medyczny, Katowice
dostęp płatny
Streszczenie
Streszczenie
Pełny tekst:
Dodaj do koszyka: 49,00 PLNSłowa kluczowe
zespół łamliwego chromosomu X, autyzm, oksytocyna
Tytuł
Perspektywy terapii oksytocyną u osób z zespołem łamliwego chromosomu X manifestującym się zaburzeniami ze spektrum autyzmu — neurobiologiczne wyjaśnienie zasadności stosowania i przegląd aktualnych danych
Czasopismo
Numer
Typ artykułu
Artykuł przeglądowy
Strony
36-47
Opublikowany online
2023-02-21
Wyświetlenia strony
438
Wyświetlenia/pobrania artykułu
70
DOI
Rekord bibliograficzny
Psychiatria 2023;20(1):36-47.
Słowa kluczowe
zespół łamliwego chromosomu X
autyzm
oksytocyna
Autorzy
Miłosz Jan Gołyszny
Marcin Drzazga
- Hall SS. Treatments for fragile X syndrome: a closer look at the data. Dev Disabil Res Rev. 2009; 15(4): 353–360.
- Turner G, Webb T, Wake S, et al. Prevalence of fragile X syndrome. Am J Med Genet. 1996; 64(1): 196–197, doi: 10.1002/(sici)1096-8628(19960712)64:1<196::aid-ajmg35>3.0.co;2-g.
- Kaufmann WE, Moser HW. Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex. 2000; 10(10): 981–991.
- Lightbody AA, Reiss AL. Gene, brain, and behavior relationships in fragile X syndrome: evidence from neuroimaging studies. Dev Disabil Res Rev. 2009; 15(4): 343–352.
- Verkerk AJ, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991; 65(5): 905–914.
- Mazzocco M. Advances in research on the fragile X syndrome. Ment Retard Dev Disabil Res Rev. 2000; 6(2): 96–106, doi: 10.1002/1098-2779(2000)6:2<96::aid-mrdd3>3.0.co;2-h.
- Schneider A, Hagerman RJ, Hessl D. Fragile X syndrome — from genes to cognition. Dev Disabil Res Rev. 2009; 15(4): 333–342.
- Oostra BA, Willems PJ. A fragile gene. Bioessays. 1995; 17(11): 941–947.
- Garber K, Visootsak J, Warren S. Fragile X syndrome. Eur J Hum Genet. 2008; 16(6): 666–672.
- Kidd SA, Lachiewicz A, Barbouth D, et al. Fragile X syndrome: a review of associated medical problems. Pediatrics. 2014; 134(5): 995–1005.
- Abbeduto L, Hagerman R. Language and communication in fragile X syndrome. Ment Retard Dev Disabil Res Rev. 1997; 3(4): 313–322, doi: 10.1002/(sici)1098-2779(1997)3:4<313::aid-mrdd6>3.0.co;2-o.
- Lozano R, Rosero CA, Hagerman RJ. Fragile X spectrum disorders. Intractable Rare Dis Res. 2014; 3(4): 134–146.
- Hodges H, Fealko C, Soares N. Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl Pediatr. 2020; 9(Suppl 1): S55–S65.
- Alisch RS, Wang T, Chopra P, et al. Genome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus. BMC Med Genet. 2013; 14: 18.
- Schopler E, Reicher R, Renner B. The Childhood Autism Rating Scale (CARS). Western Psychological Services, Los Angeles 1988: 91–103.
- Sparrow SS, Balla DA, Cichetti DV. Vineland Adaptive Behavior Scales VABS: expanded form manual. American Guidance Service, Circle Pines 1984: 497–507.
- Mullen EM. Mullen scales of early learning. American Guidance Service, Circle Pines 1995: 58–64.
- McDuffie A, Thurman AJ, Hagerman RJ, et al. Symptoms of autism in males with fragile X syndrome: a comparison to nonsyndromic ASD using current ADI-R scores. J Autism Dev Disord. 2015; 45(7): 1925–1937.
- Harris J. Leo Kanner and autism: a 75-year perspective. Int Rev Psychiatry. 2018; 30(1): 3–17.
- Riddle K, Cascio CJ, Woodward ND. Brain structure in autism: a voxel-based morphometry analysis of the Autism Brain Imaging Database Exchange (ABIDE). Brain Imaging Behav. 2017; 11(2): 541–551.
- Masi A, Glozier N, Dale R, et al. The immune system, cytokines, and biomarkers in autism spectrum disorder. Neurosci Bull. 2017; 33(2): 194–204.
- Marotta R, Risoleo MC, Messina G, et al. The neurochemistry of autism. Brain Sci. 2020; 10(3).
- Cheroni C, Caporale N, Testa G. Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology. Mol Autism. 2020; 11(1): 69.
- Huijnen C, Lexis MAS, Witte Lde. Robots as new tools in therapy and education for children with autism. International Journal of Neurorehabilitation. 2017; 04(04).
- Rudovic O, Lee J, Dai M, et al. Personalized machine learning for robot perception of affect and engagement in autism therapy. Sci Robot. 2018; 3(19).
- Kang DW, Adams JB, Coleman DM, et al. Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota. Sci Rep. 2019; 9(1): 5821.
- Wijker C, Leontjevas R, Spek A, et al. Process evaluation of animal-assisted therapy: feasibility and relevance of a dog-assisted therapy program in adults with autism spectrum disorder. Animals (Basel). 2019; 9(12).
- Marquez-Garcia A, Magnuson J, Morris J, et al. Music therapy in autism spectrum disorder: a systematic review. Review Journal of Autism and Developmental Disorders. 2021; 9(1): 91–107.
- Lange KW, Hauser J, Reissmann A. Gluten-free and casein-free diets in the therapy of autism. Curr Opin Clin Nutr Metab Care. 2015; 18(6): 572–575.
- Podgórska-Bednarz J, Perenc L. Hyperbaric oxygen therapy for children and youth with autism spectrum disorder: a review. Brain Sci. 2021; 11(7).
- Brito A, Russo FB, Muotri AR, et al. Autism spectrum disorders and disease modeling using stem cells. Cell Tissue Res. 2018; 371(1): 153–160.
- Carter CS. Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders? Behav Brain Res. 2007; 176(1): 170–186.
- Froemke RC, Young LJ. Oxytocin, neural plasticity, and social behavior. Annu Rev Neurosci. 2021; 44: 359–381.
- Mottolese R, Redouté J, Costes N, et al. Switching brain serotonin with oxytocin. Proc Natl Acad Sci U S A. 2014; 111(23): 8637–8642.
- Pohl TT, Young LJ, Bosch OJ. Lost connections: oxytocin and the neural, physiological, and behavioral consequences of disrupted relationships. Int J Psychophysiol. 2019; 136: 54–63.
- Boccia ML, Petrusz P, Suzuki K, et al. Immunohistochemical localization of oxytocin receptors in human brain. Neuroscience. 2013; 253: 155–164.
- Windle RJ, Kershaw YM, Shanks N, et al. Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J Neurosci. 2004; 24(12): 2974–2982.
- Gołyszny M. „Stare” i „nowe” neuropeptydy jako modulatory czynności osi stresu (podwzgórze–przysadka–nadnercza). Varia Medica. 2018; 2(5): 409–422.
- Windle RJ, Shanks N, Lightman SL, et al. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinol. 1997; 138(7): 2829–2834.
- Kirsch P, Esslinger C, Chen Q, et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci. 2005; 25(49): 11489–11493.
- Quirin M, Kuhl J, Düsing R. Oxytocin buffers cortisol responses to stress in individuals with impaired emotion regulation abilities. Psychoneuroendocrinology. 2011; 36(6): 898–904.
- Nauta WJ. Hippocampal projections and related neural pathways to the midbrain in the cat. Brain. 1958; 81(3): 319–340.
- Mason JW, Nauta WJ, Brady JV, et al. The role of limbic system structures in the regulation of ACTH secretion. Acta Neuroveg (Wien). 1961; 23: 4–14.
- Nauta WJ, Domesick VB. Neural associations of the limbic system. In: Beckman AL. ed. The neural basis of behavior. Springer, Dordrecht 1982: 175–206.
- Huber D, Veinante P, Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science. 2005; 308(5719): 245–248.
- Olff M. Bonding after trauma: on the role of social support and the oxytocin system in traumatic stress. Eur J Psychotraumatol. 2012; 3.
- Viviani D, Charlet A, van den Burg E, et al. Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science. 2011; 333(6038): 104–107.
- Domes G, Heinrichs M, Gläscher J, et al. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry. 2007; 62(10): 1187–1190.
- Sripada CS, Phan KL, Labuschagne I, et al. Oxytocin enhances resting-state connectivity between amygdala and medial frontal cortex. Int J Neuropsychopharmacol. 2013; 16(2): 255–260.
- MacLean P. A triune concept of the brain and behaviour. University of Toronto Press, Toronto 1973.
- Ferguson JN, Young LJ, Hearn EF, et al. Social amnesia in mice lacking the oxytocin gene. Nat Genet. 2000; 25(3): 284–288.
- Williams JR, Carter CS, Insel T. Partner preference development in female prairie voles is facilitated by mating or the central infusion of oxytocin. Ann N Y Acad Sci. 1992; 652: 487–489.
- Witt DM, Winslow JT, Insel TR. Enhanced social interactions in rats following chronic, centrally infused oxytocin. Pharmacol Biochem Behav. 1992; 43(3): 855–861.
- Insel TR, Winslow JT. Central administration of oxytocin modulates the infant rat's response to social isolation. Eur J Pharmacol. 1991; 203(1): 149–152.
- Grippo AJ, Trahanas DM, Zimmerman RR, et al. Oxytocin protects against negative behavioral and autonomic consequences of long-term social isolation. Psychoneuroendocrinology. 2009; 34(10): 1542–1553.
- Kubzansky LD, Mendes WB, Appleton AA, et al. A heartfelt response: Oxytocin effects on response to social stress in men and women. Biol Psychol. 2012; 90(1): 1–9.
- Smith AS, Wang Z. Salubrious effects of oxytocin on social stress-induced deficits. Horm Behav. 2012; 61(3): 320–330.
- Gordon I, Jack A, Pretzsch CM, et al. Intranasal oxytocin enhances connectivity in the neural circuitry supporting social motivation and social perception in children with autism. Sci Rep. 2016; 6: 35054.
- Deuse L, Wudarczyk O, Rademacher L, et al. Peripheral oxytocin predicts higher-level social cognition in men regardless of empathy quotient. Pharmacopsychiatry. 2019; 52(3): 148–154.
- Thomas S, Larkin T. Plasma cortisol and oxytocin levels predict help-seeking intentions for depressive symptoms. Psychoneuroendocrinology. 2018; 87: 159–165.
- Kanai R, Bahrami B, Duchaine B, et al. Brain structure links loneliness to social perception. Curr Biol. 2012; 22(20): 1975–1979.
- Bickart KC, Wright CI, Dautoff RJ, et al. Amygdala volume and social network size in humans. Nat Neurosci. 2011; 14(2): 163–164.
- Powell J, Lewis PA, Roberts N, et al. Orbital prefrontal cortex volume predicts social network size: an imaging study of individual differences in humans. Proc Biol Sci. 2012; 279(1736): 2157–2162.
- Lewis PA, Rezaie R, Brown R, et al. Ventromedial prefrontal volume predicts understanding of others and social network size. Neuroimage. 2011; 57(4): 1624–1629.
- Powell JL, Lewis PA, Dunbar RIM, et al. Orbital prefrontal cortex volume correlates with social cognitive competence. Neuropsychologia. 2010; 48(12): 3554–3562.
- Mitchell RLC, Phillips LH. The overlapping relationship between emotion perception and theory of mind. Neuropsychologia. 2015; 70: 1–10.
- Dölen G, Darvishzadeh A, Huang KW, et al. Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature. 2013; 501(7466): 179–184.
- Vacher CM, Frétier P, Créminon C, et al. Activation by serotonin and noradrenaline of vasopressin and oxytocin expression in the mouse paraventricular and supraoptic nuclei. J Neurosci. 2002; 22(5): 1513–1522.
- Blanchard RJ, McKittrick CR, Blanchard DC. Animal models of social stress: effects on behavior and brain neurochemical systems. Physiol Behav. 2001; 73(3): 261–271.
- Onaka T, Ikeda K, Yamashita T, et al. Facilitative role of endogenous oxytocin in noradrenaline release in the rat supraoptic nucleus. Eur J Neurosci. 2003; 18(11): 3018–3026.
- Tidey JW, Miczek KA. Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain Res. 1996; 721(1-2): 140–149.
- Tidey JW, Miczek KA. Acquisition of cocaine self-administration after social stress: role of accumbens dopamine. Psychopharmacology (Berl). 1997; 130(3): 203–212.
- Shively CA. Social subordination stress, behavior, and central monoaminergic function in female cynomolgus monkeys. Biol Psychiatry. 1998; 44(9): 882–891.
- Love TM. Oxytocin, motivation and the role of dopamine. Pharmacol Biochem Behav. 2014; 119: 49–60.
- Borland JM, Grantham KN, Aiani LM, et al. Role of oxytocin in the ventral tegmental area in social reinforcement. Psychoneuroendocrinology. 2018; 95: 128–137.
- Abu-Akel A, Shamay-Tsoory S. Neuroanatomical and neurochemical bases of theory of mind. Neuropsychologia. 2011; 49(11): 2971–2984.
- Born J, Lange T, Kern W, et al. Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci. 2002; 5(6): 514–516.
- Macdonald K, Macdonald TM. The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv Rev Psychiatry. 2010; 18(1): 1–21.
- Leppanen J, Ng KW, Tchanturia K, et al. Meta-analysis of the effects of intranasal oxytocin on interpretation and expression of emotions. Neurosci Biobehav Rev. 2017; 78: 125–144.
- Pedersen CA, Gibson CM, Rau SW, et al. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophr Res. 2011; 132(1): 50–53.
- LoParo D, Waldman ID. The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis. Mol Psychiatry. 2015; 20(5): 640–646.
- Pobbe RLH, Pearson BL, Defensor EB, et al. Oxytocin receptor knockout mice display deficits in the expression of autism-related behaviors. Horm Behav. 2012; 61(3): 436–444.
- Skuse DH, Lori A, Cubells JF, et al. Common polymorphism in the oxytocin receptor gene (OXTR) is associated with human social recognition skills. Proc Natl Acad Sci U S A. 2014; 111(5): 1987–1992.
- Jesner OS, Aref-Adib M, Coren E. Risperidone for autism spectrum disorder. Cochrane Database Syst Rev. 2007; 2007(1): CD005040.
- Farmer L. Library services for youth with autism. IASL Annual Conference Proceedings. 2021.
- Preti A, Melis M, Siddi S, et al. Oxytocin and autism: a systematic review of randomized controlled trials. J Child Adolesc Psychopharmacol. 2014; 24(2): 54–68.
- Hollander E, Novotny S, Hanratty M, et al. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology. 2003; 28(1): 193–198.
- Anagnostou E, Soorya L, Chaplin W, et al. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Mol Autism. 2012; 3(1): 16.
- Andari E, Duhamel JR, Zalla T, et al. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci U S A. 2010; 107(9): 4389–4394.
- Auyeung B, Lombardo MV, Heinrichs M, et al. Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism. Transl Psychiatry. 2015; 5(2): e507.
- Dadds MR, MacDonald E, Cauchi A, et al. Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial. J Autism Dev Disord. 2014; 44(3): 521–531.
- Hollander E, Bartz J, Chaplin W, et al. Oxytocin increases retention of social cognition in autism. Biol Psychiatry. 2007; 61(4): 498–503.
- Yatawara CJ, Einfeld SL, Hickie IB, et al. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial. Mol Psychiatry. 2016; 21(9): 1225–1231.
- Kosaka H, Okamoto Y, Munesue T, et al. Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial. Transl Psychiatry. 2016; 6(8): e872.
- Domes G, Kumbier E, Heinrichs M, et al. Oxytocin promotes facial emotion recognition and amygdala reactivity in adults with asperger syndrome. Neuropsychopharmacology. 2014; 39(3): 698–706.
- Watanabe T, Kuroda M, Kuwabara H, et al. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism. Brain. 2015; 138(Pt 11): 3400–3412.
- Zink CF, Meyer-Lindenberg A. Human neuroimaging of oxytocin and vasopressin in social cognition. Horm Behav. 2012; 61(3): 400–409.
- Monk CS, Weng SJ, Wiggins JL, et al. Neural circuitry of emotional face processing in autism spectrum disorders. J Psychiatry Neurosci. 2010; 35(2): 105–114.
- Weng SJ, Carrasco M, Swartz JR, et al. Neural activation to emotional faces in adolescents with autism spectrum disorders. J Child Psychol Psychiatry. 2011; 52(3): 296–305.
- Perlman SB, Hudac CM, Pegors T, et al. Experimental manipulation of face-evoked activity in the fusiform gyrus of individuals with autism. Soc Neurosci. 2011; 6(1): 22–30.
- Kleinhans NM, Richards T, Johnson LC, et al. fMRI evidence of neural abnormalities in the subcortical face processing system in ASD. Neuroimage. 2011; 54(1): 697–704.
- Dalton KM, Nacewicz BM, Johnstone T, et al. Gaze fixation and the neural circuitry of face processing in autism. Nat Neurosci. 2005; 8(4): 519–526.
- Bookheimer SY, Wang AT, Scott A, et al. Frontal contributions to face processing differences in autism: evidence from fMRI of inverted face processing. J Int Neuropsychol Soc. 2008; 14(6): 922–932.
- Atkinson AP, Adolphs R. The neuropsychology of face perception: beyond simple dissociations and functional selectivity. Philos Trans R Soc Lond B Biol Sci. 2011; 366(1571): 1726–1738.
- Shamay-Tsoory SG. The neural bases for empathy. Neuroscientist. 2011; 17(1): 18–24.
- Hall SS, Lightbody AA, McCarthy BE, et al. Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome. Psychoneuroendocrinology. 2012; 37(4): 509–518.
- Petrovic P, Kalisch R, Singer T, et al. Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci. 2008; 28(26): 6607–6615.
- Smith R. Moving molecules: mRNA trafficking in Mammalian oligodendrocytes and neurons. Neuroscientist. 2004; 10(6): 495–500.
- Carter CS, Grippo AJ, Pournajafi-Nazarloo H, et al. Oxytocin, vasopressin and sociality. Prog Brain Res. 2008; 170: 331–336.
- Hessl D, Rivera SM, Reiss AL. The neuroanatomy and neuroendocrinology of fragile X syndrome. Ment Retard Dev Disabil Res Rev. 2004; 10(1): 17–24.
- Parker KJ, Buckmaster CL, Schatzberg AF, et al. Intranasal oxytocin administration attenuates the ACTH stress response in monkeys. Psychoneuroendocrinology. 2005; 30(9): 924–929.
- Tiedge H, Zhou A, Thorn NA, et al. Transport of BC1 RNA in hypothalamo-neurohypophyseal axons. J Neurosci. 1993; 13(10): 4214–4219.
- Modabbernia A, Rezaei F, Salehi B, et al. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study. CNS Drugs. 2013; 27(1): 57–65.
- Medved S, Bajs JanoviĆ M, Štimac Z, et al. Add-on oxytocin in the treatment of postpartum acute schizophrenia: a case report. J Psychiatr Pract. 2021; 27(4): 326–332.
- Cai Q, Feng L, Yap KZ. Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder. Psychiatry Clin Neurosci. 2018; 72(3): 140–151.
- Wang Y, Wang MJ, Rong Y, et al. Oxytocin therapy for core symptoms in autism spectrum disorder: An updated meta-analysis of randomized controlled trials. Research in Autism Spectrum Disorders. 2019; 64: 63–75.
- Rybak-Korneluk A, Wichowicz H, Żuk K, et al. Autobiographical memory and its meaning in selected mental disorders. Psychiatr Pol. 2016; 50(5): 959–972.
- Lisik MZ, Janas-Kozik M, Krupka-Matuszczyk I. Zespół łamliwego chromosomu X – problem dziecka i rodziców. Psychiatr Pol. 2011; 45: 357–365.
- Guastella AJ, Mitchell PB, Mathews F. Oxytocin enhances the encoding of positive social memories in humans. Biol Psychiatry. 2008; 64(3): 256–258.
- Savaskan E, Ehrhardt R, Schulz A, et al. Post-learning intranasal oxytocin modulates human memory for facial identity. Psychoneuroendocrinology. 2008; 33(3): 368–374.
- Gülpinar MA, Yegen BC. The physiology of learning and memory: role of peptides and stress. Curr Protein Pept Sci. 2004; 5(6): 457–473.
- Ferrier BM, Kennett DJ, Devlin MC. Influence of oxytocin on human memory processes. Life Sci. 1980; 27(24): 2311–2317.
- Geenen V, Adam F, Baro V, et al. Inhibitory influence of oxytocin infusion on contingent negative variation and some memory tasks in normal men. Psychoneuroendocrinology. 1988; 13(5): 367–375.
- Fischer-Shofty M, Shamay-Tsoory SG, Harari H, et al. The effect of intranasal administration of oxytocin on fear recognition. Neuropsychologia. 2010; 48(1): 179–184.
- Evans SL, Dal Monte O, Noble P, et al. Intranasal oxytocin effects on social cognition: a critique. Brain Res. 2014; 1580: 69–77.
- Leng G, Ludwig M. Intranasal oxytocin: myths and delusions. Biol Psychiatry. 2016; 79(3): 243–250.
- Quintana DS. Most oxytocin administration studies are statistically underpowered to reliably detect (or reject) a wide range of effect sizes. Compr Psychoneuroendocrinol. 2020; 4: 100014.
- Aoki Y, Watanabe T, Abe O, et al. Oxytocin's neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial. Mol Psychiatry. 2015; 20(4): 447–453.
- Guastella AJ, Einfeld SL, Gray KM, et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry. 2010; 67(7): 692–694.
- Guastella AJ, Gray KM, Rinehart NJ, et al. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial. J Child Psychol Psychiatry. 2015; 56(4): 444–452.